Cargando…
Increasing transparency and accountability in national pharmaceutical systems
Access to safe, effective, good-quality medicines can be compromised by poor pharmaceutical system governance. This system is particularly vulnerable to inefficiencies and to losses from corruption, because it involves a complex mix of actors with diverse responsibilities. A high level of transparen...
Autores principales: | Paschke, Anne, Dimancesco, Deirdre, Vian, Taryn, Kohler, Jillian C, Forte, Gilles |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
World Health Organization
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6239016/ https://www.ncbi.nlm.nih.gov/pubmed/30455533 http://dx.doi.org/10.2471/BLT.17.206516 |
Ejemplares similares
-
Promoting transparency, accountability, and access through a multi-stakeholder initiative: lessons from the medicines transparency alliance
por: Vian, Taryn, et al.
Publicado: (2017) -
The risk of corruption in public pharmaceutical procurement: how anti-corruption, transparency and accountability measures may reduce this risk
por: Kohler, Jillian Clare, et al.
Publicado: (2020) -
Disclosure, transparency, and accountability: a qualitative survey of public sector pharmaceutical committee conflict of interest policies in the World Health Organization South-East Asia Region
por: Grundy, Quinn, et al.
Publicado: (2022) -
The sustainable development goals as a framework to combat health-sector corruption
por: Mackey, Tim K, et al.
Publicado: (2018) -
Anti-corruption, transparency and accountability in health: concepts, frameworks, and approaches
por: Vian, Taryn
Publicado: (2020)